Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This has reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ,2015, please find attached the details of meeting held/to be held with Analyst/Institutional Investor.
Buy Syngene International; target of Rs 780: ICICI Direct
ICICI Direct is bullish on Syngene International has recommended buy rating on the stock with a target price of Rs 780 in its research report dated July 22, 2021. Syngene International Ltd - 539268 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Syngene International Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Reg 30 of SEBI LODR we wish to inform you the following appointment/reappointment passed by the shareholders at the 28th AGM held on July 21, 2021. 1. Appointment of Dr Kush Parmar (DIN: 09212020) as the Independent Director on the Board of Directors of the Company, for a first term from the date of appointment by the Board (22nd June, 2021) until the conclusion of the 31st AGM of the Company proposed to be held in 2024. The brief profile of Dr Kush Parmar is enclosed as Annexure A. 2. Re-appointment of M/s B S R & Co. LLP, Chartered Accountants, bearing Registration Number 101248W/W-100022 as the Statutory Auditors of the Company for a term of five consecutive years from the conclusion of this (28th) Annual General Meeting until the conclusion of AGM to be held in the year 2026 on such remuneration as may be fixed by the Board of Directors in consultation with the Statutory Auditors of the Company. Syngene International Ltd - 539268 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Subject: Subject: Voting results under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We hereby submit the results of voting concluded at the 28th Annual General Meeting of Syngene International Limited held on July 21, 2021, on all the resolutions set forth in the AGM Notice dated June 22, 2021. We would like to inform you that resolution nos. 1 to 4 have been approved with the requisite majority by the shareholders of the Company. The details of votes cast by shareholders are given in the attached Annexure A. As required under Section 108 of the Companies Act, 2013 read with Rule 20(4) of the Companies (Management and Administration) Rules, 2014, as amended, the consolidated Scrutinizer's Report on the remote e-voting and voting through Insta-poll is also enclosed. Syngene International Ltd - 539268 - Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the above-mentioned subject, we hereby enclose the proceedings of the 28th Annual General Meeting held on Wednesday, July 21, 2021 at 03:30 p.m. through video conferencing. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated July 20, 2021, regarding outcome of the Board Meeting and financials for the quarter ended June 30, 2021, please find enclosed herewith the copy of newspaper publication of the financials in Financial Express (All India Edition) and Vijayavani (Bengaluru Edition) on July 22, 2021. Remdesivir production boosted our June quarter growth strongly: Syngene CEO
In FY22, we will invest in expanding our biologics plant, research facilities'
Earnings Call for Q1FY22 of Syngene International
Conference Call with Syngene International Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript. Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. John M M Shaw (DIN: 00347250) (Non-Executive, Non- Independent Director), vide his letter dated July 20, 2021 has communicated his intention to step down from the Board of Directors of the Company due to health reasons with effect from conclusion of the Annual General Meeting of the Company scheduled on July 21, 2021.